Literature DB >> 21701067

Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice.

Katerina Vlantis1, Andy Wullaert, Yoshiteru Sasaki, Marc Schmidt-Supprian, Klaus Rajewsky, Tania Roskams, Manolis Pasparakis.   

Abstract

Many cancers display increased NF-κB activity, and NF-κB inhibition is known to diminish tumor development in multiple mouse models, supporting an important role of NF-κB in carcinogenesis. NF-κB activation in premalignant or cancer cells is believed to promote tumor development mainly by protecting these cells from apoptosis. However, it remains unclear to what extent NF-κB activation exhibits additional protumorigenic functions in premalignant cells that could be sufficient to induce spontaneous tumor development. Here we show that expression of constitutively active IκB kinase 2 (IKK2ca) in mouse intestinal epithelial cells (IECs) induced spontaneous tumors in aged mice and also strongly enhanced chemical- and Apc mutation-mediated carcinogenesis. IECs expressing IKK2ca displayed altered Wnt signaling and increased proliferation and elevated expression of genes encoding intestinal stem cell-associated factors including Ascl2, Olfm4, DLK1, and Bmi-1, indicating that increased IKK2/NF-κB activation synergized with Wnt signaling to drive intestinal tumorigenesis. Moreover, IECs expressing IKK2ca produced cytokines and chemokines that induced the recruitment of myeloid cells and activated stromal fibroblasts to become myofibroblasts, thus creating a tumor-promoting microenvironment. Taken together, our results show that constitutively increased activation of IKK2/NF-κB signaling in the intestinal epithelium is sufficient to induce the full spectrum of cell-intrinsic and stromal alterations required for intestinal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701067      PMCID: PMC3223831          DOI: 10.1172/JCI45349

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  67 in total

1.  Transcription of the RelB gene is regulated by NF-kappaB.

Authors:  G D Bren; N J Solan; H Miyoshi; K N Pennington; L J Pobst; C V Paya
Journal:  Oncogene       Date:  2001-11-22       Impact factor: 9.867

Review 2.  The intestinal stem cell.

Authors:  Nick Barker; Marc van de Wetering; Hans Clevers
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

3.  In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.

Authors:  C Becker; M C Fantini; S Wirtz; A Nikolaev; R Kiesslich; H A Lehr; P R Galle; M F Neurath
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 4.  Wnt/beta-catenin signaling in cancer stemness and malignant behavior.

Authors:  Riccardo Fodde; Thomas Brabletz
Journal:  Curr Opin Cell Biol       Date:  2007-02-16       Impact factor: 8.382

5.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

6.  Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin.

Authors:  Shahid Umar; Shubhashish Sarkar; Yu Wang; Pomila Singh
Journal:  J Biol Chem       Date:  2009-06-04       Impact factor: 5.157

7.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

9.  Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation.

Authors:  Kris A Steinbrecher; Eleana Harmel-Laws; Raquel Sitcheran; Albert S Baldwin
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

10.  Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

Authors:  Sya N Ukena; Anurag Singh; Ulrike Dringenberg; Regina Engelhardt; Ursula Seidler; Wiebke Hansen; André Bleich; Dunja Bruder; Anke Franzke; Gerhard Rogler; Sebastian Suerbaum; Jan Buer; Florian Gunzer; Astrid M Westendorf
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

View more
  56 in total

Review 1.  NF-κB signaling in cancer stem cells: a promising therapeutic target?

Authors:  K Vazquez-Santillan; J Melendez-Zajgla; L Jimenez-Hernandez; G Martínez-Ruiz; V Maldonado
Journal:  Cell Oncol (Dordr)       Date:  2015-08-29       Impact factor: 6.730

2.  Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer.

Authors:  Jens U Marquardt; Luis Gomez-Quiroz; Lucrecia O Arreguin Camacho; Federico Pinna; Yun-Han Lee; Mitsuteru Kitade; Mayrel Palestino Domínguez; Darko Castven; Kai Breuhahn; Elizabeth A Conner; Peter R Galle; Jesper B Andersen; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2015-05-01       Impact factor: 25.083

Review 3.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis.

Authors:  Lance W Peterson; David Artis
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

4.  Intestinal carcinogenesis: IKK can go all the way.

Authors:  Yoshiaki Sunami; Thomas Wirth
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

5.  The ubiquitin ligase ITCH coordinates small intestinal epithelial homeostasis by modulating cell proliferation, differentiation, and migration.

Authors:  Heather L Mentrup; Amanda Hartman; Elizabeth L Thames; Wassim A Basheer; Lydia E Matesic
Journal:  Differentiation       Date:  2017-12-15       Impact factor: 3.880

6.  PHF20 regulates NF-κB signalling by disrupting recruitment of PP2A to p65.

Authors:  Tiejun Zhang; Kyeong Ah Park; Yuwen Li; Hee Sun Byun; Juhee Jeon; Yoonjung Lee; Jang Hee Hong; Jin Man Kim; Song-Mei Huang; Seung-Won Choi; Seon-Hwan Kim; Kyung-Cheol Sohn; Hyunju Ro; Ji Hoon Lee; Tao Lu; George R Stark; Han-Ming Shen; Zheng-Gang Liu; Jongsun Park; Gang Min Hur
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

7.  Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation.

Authors:  Helena Shaked; Lorne J Hofseth; Alena Chumanevich; Alexander A Chumanevich; Jin Wang; Yinsheng Wang; Koji Taniguchi; Monica Guma; Steve Shenouda; Hans Clevers; Curtis C Harris; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-14       Impact factor: 11.205

Review 8.  DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2014-08-07       Impact factor: 9.261

Review 9.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

10.  Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Authors:  Tomer Cooks; Ioannis S Pateras; Ohad Tarcic; Hilla Solomon; Aaron J Schetter; Sylvia Wilder; Guillermina Lozano; Eli Pikarsky; Tim Forshew; Nitzan Rosenfeld; Nitzan Rozenfeld; Noam Harpaz; Steven Itzkowitz; Curtis C Harris; Varda Rotter; Vassilis G Gorgoulis; Moshe Oren
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.